Neighborhood Social Vulnerability and Racial Disparities in Schizophrenia Spectrum Disorder Prevalence

The study aim was to identify ethnoracial disparities in the prevalence of schizophrenia spectrum disorders (SSDs) and positive psychotic symptoms in the United States and examine the role of social neighborhood inequities. Participants in the Mental and Substance Use Disorders Prevalence Study, a n...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of psychiatry Vol. 182; no. 9; p. 850
Main Authors: Anglin, Deidre M, Olfson, Mark, van der Ven, Els, Oh, Hans, Lewis-Fernández, Roberto, DeVylder, Jordan, Oluwoye, Oladunni, Dixon, Lisa, Stroup, T Scott, Guyer, Heidi, Bareis, Natalie
Format: Journal Article
Language:English
Published: United States 01.09.2025
Subjects:
ISSN:1535-7228, 1535-7228
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The study aim was to identify ethnoracial disparities in the prevalence of schizophrenia spectrum disorders (SSDs) and positive psychotic symptoms in the United States and examine the role of social neighborhood inequities. Participants in the Mental and Substance Use Disorders Prevalence Study, a national household sample of nonelderly adults (N=4,764), were assessed by clinicians with the Structured Clinical Interview for DSM-5 (SCID-5) for SSDs (past year and lifetime), including schizophrenia, schizoaffective disorder, and schizophreniform disorder, and for psychotic symptoms. Weighted logistic regression models estimated ethnoracial differences in the prevalence of SSDs and psychotic symptoms in unadjusted models, age- and sex-adjusted models, and models further adjusted for a neighborhood Social Vulnerability Metric (SVM) score, a composite index of five social determinants of health domains. Compared to non-Hispanic White individuals, non-Hispanic Black individuals had a significantly higher prevalence of SSDs (4.1% vs. 1.2%; adjusted odds ratio=3.49, 95% CI=1.37, 8.91) and psychotic symptoms (9.3% vs. 4.9%; adjusted odds ratio=2.04, 95% CI=1.15, 3.63), and non-Hispanic multiracial individuals had a significantly higher prevalence of SSDs (5.6%; adjusted odds ratio=4.59, 95% CI=1.53, 13.76). Further adjustment for SVM score lowered the Black-White group difference for SSDs (adjusted odds ratio=2.49, 95% CI=0.63, 9.90) and psychotic symptoms (adjusted odds ratio=1.69, 95% CI=0.83, 3.44), and the associations were no longer statistically significant. The difference in SSDs between the non-Hispanic multiracial and White groups was attenuated after SVM score adjustment (adjusted odds ratio=3.95, 95% CI=1.30, 12.00) but remained significant. This national U.S. household study found ethnoracial differences in the prevalence of clinician-assessed SCID-based schizophrenia spectrum disorders and positive psychotic symptoms. The higher prevalence among minoritized groups, particularly Black individuals, was connected to social inequities and community-level vulnerabilities embedded in neighborhoods and associated with structural racism.
AbstractList The study aim was to identify ethnoracial disparities in the prevalence of schizophrenia spectrum disorders (SSDs) and positive psychotic symptoms in the United States and examine the role of social neighborhood inequities.OBJECTIVEThe study aim was to identify ethnoracial disparities in the prevalence of schizophrenia spectrum disorders (SSDs) and positive psychotic symptoms in the United States and examine the role of social neighborhood inequities.Participants in the Mental and Substance Use Disorders Prevalence Study, a national household sample of nonelderly adults (N=4,764), were assessed by clinicians with the Structured Clinical Interview for DSM-5 (SCID-5) for SSDs (past year and lifetime), including schizophrenia, schizoaffective disorder, and schizophreniform disorder, and for psychotic symptoms. Weighted logistic regression models estimated ethnoracial differences in the prevalence of SSDs and psychotic symptoms in unadjusted models, age- and sex-adjusted models, and models further adjusted for a neighborhood Social Vulnerability Metric (SVM) score, a composite index of five social determinants of health domains.METHODSParticipants in the Mental and Substance Use Disorders Prevalence Study, a national household sample of nonelderly adults (N=4,764), were assessed by clinicians with the Structured Clinical Interview for DSM-5 (SCID-5) for SSDs (past year and lifetime), including schizophrenia, schizoaffective disorder, and schizophreniform disorder, and for psychotic symptoms. Weighted logistic regression models estimated ethnoracial differences in the prevalence of SSDs and psychotic symptoms in unadjusted models, age- and sex-adjusted models, and models further adjusted for a neighborhood Social Vulnerability Metric (SVM) score, a composite index of five social determinants of health domains.Compared to non-Hispanic White individuals, non-Hispanic Black individuals had a significantly higher prevalence of SSDs (4.1% vs. 1.2%; adjusted odds ratio=3.49, 95% CI=1.37, 8.91) and psychotic symptoms (9.3% vs. 4.9%; adjusted odds ratio=2.04, 95% CI=1.15, 3.63), and non-Hispanic multiracial individuals had a significantly higher prevalence of SSDs (5.6%; adjusted odds ratio=4.59, 95% CI=1.53, 13.76). Further adjustment for SVM score lowered the Black-White group difference for SSDs (adjusted odds ratio=2.49, 95% CI=0.63, 9.90) and psychotic symptoms (adjusted odds ratio=1.69, 95% CI=0.83, 3.44), and the associations were no longer statistically significant. The difference in SSDs between the non-Hispanic multiracial and White groups was attenuated after SVM score adjustment (adjusted odds ratio=3.95, 95% CI=1.30, 12.00) but remained significant.RESULTSCompared to non-Hispanic White individuals, non-Hispanic Black individuals had a significantly higher prevalence of SSDs (4.1% vs. 1.2%; adjusted odds ratio=3.49, 95% CI=1.37, 8.91) and psychotic symptoms (9.3% vs. 4.9%; adjusted odds ratio=2.04, 95% CI=1.15, 3.63), and non-Hispanic multiracial individuals had a significantly higher prevalence of SSDs (5.6%; adjusted odds ratio=4.59, 95% CI=1.53, 13.76). Further adjustment for SVM score lowered the Black-White group difference for SSDs (adjusted odds ratio=2.49, 95% CI=0.63, 9.90) and psychotic symptoms (adjusted odds ratio=1.69, 95% CI=0.83, 3.44), and the associations were no longer statistically significant. The difference in SSDs between the non-Hispanic multiracial and White groups was attenuated after SVM score adjustment (adjusted odds ratio=3.95, 95% CI=1.30, 12.00) but remained significant.This national U.S. household study found ethnoracial differences in the prevalence of clinician-assessed SCID-based schizophrenia spectrum disorders and positive psychotic symptoms. The higher prevalence among minoritized groups, particularly Black individuals, was connected to social inequities and community-level vulnerabilities embedded in neighborhoods and associated with structural racism.CONCLUSIONSThis national U.S. household study found ethnoracial differences in the prevalence of clinician-assessed SCID-based schizophrenia spectrum disorders and positive psychotic symptoms. The higher prevalence among minoritized groups, particularly Black individuals, was connected to social inequities and community-level vulnerabilities embedded in neighborhoods and associated with structural racism.
The study aim was to identify ethnoracial disparities in the prevalence of schizophrenia spectrum disorders (SSDs) and positive psychotic symptoms in the United States and examine the role of social neighborhood inequities. Participants in the Mental and Substance Use Disorders Prevalence Study, a national household sample of nonelderly adults (N=4,764), were assessed by clinicians with the Structured Clinical Interview for DSM-5 (SCID-5) for SSDs (past year and lifetime), including schizophrenia, schizoaffective disorder, and schizophreniform disorder, and for psychotic symptoms. Weighted logistic regression models estimated ethnoracial differences in the prevalence of SSDs and psychotic symptoms in unadjusted models, age- and sex-adjusted models, and models further adjusted for a neighborhood Social Vulnerability Metric (SVM) score, a composite index of five social determinants of health domains. Compared to non-Hispanic White individuals, non-Hispanic Black individuals had a significantly higher prevalence of SSDs (4.1% vs. 1.2%; adjusted odds ratio=3.49, 95% CI=1.37, 8.91) and psychotic symptoms (9.3% vs. 4.9%; adjusted odds ratio=2.04, 95% CI=1.15, 3.63), and non-Hispanic multiracial individuals had a significantly higher prevalence of SSDs (5.6%; adjusted odds ratio=4.59, 95% CI=1.53, 13.76). Further adjustment for SVM score lowered the Black-White group difference for SSDs (adjusted odds ratio=2.49, 95% CI=0.63, 9.90) and psychotic symptoms (adjusted odds ratio=1.69, 95% CI=0.83, 3.44), and the associations were no longer statistically significant. The difference in SSDs between the non-Hispanic multiracial and White groups was attenuated after SVM score adjustment (adjusted odds ratio=3.95, 95% CI=1.30, 12.00) but remained significant. This national U.S. household study found ethnoracial differences in the prevalence of clinician-assessed SCID-based schizophrenia spectrum disorders and positive psychotic symptoms. The higher prevalence among minoritized groups, particularly Black individuals, was connected to social inequities and community-level vulnerabilities embedded in neighborhoods and associated with structural racism.
Author Olfson, Mark
Bareis, Natalie
Oh, Hans
Lewis-Fernández, Roberto
Oluwoye, Oladunni
Anglin, Deidre M
van der Ven, Els
DeVylder, Jordan
Dixon, Lisa
Stroup, T Scott
Guyer, Heidi
Author_xml – sequence: 1
  givenname: Deidre M
  orcidid: 0000-0002-2717-3206
  surname: Anglin
  fullname: Anglin, Deidre M
  organization: City University of New York Graduate Center, New York
– sequence: 2
  givenname: Mark
  orcidid: 0000-0002-3958-5662
  surname: Olfson
  fullname: Olfson, Mark
  organization: New York State Psychiatric Institute, New York
– sequence: 3
  givenname: Els
  orcidid: 0000-0001-5103-7186
  surname: van der Ven
  fullname: van der Ven, Els
  organization: Department of Clinical, Neuro-, and Developmental Psychology, Vrije Universiteit Amsterdam
– sequence: 4
  givenname: Hans
  surname: Oh
  fullname: Oh, Hans
  organization: School of Social Work, University of Southern California, Los Angeles
– sequence: 5
  givenname: Roberto
  orcidid: 0000-0003-1305-7471
  surname: Lewis-Fernández
  fullname: Lewis-Fernández, Roberto
  organization: New York State Psychiatric Institute, New York
– sequence: 6
  givenname: Jordan
  orcidid: 0000-0001-5873-4582
  surname: DeVylder
  fullname: DeVylder, Jordan
  organization: Silver School of Social Work, New York University, New York
– sequence: 7
  givenname: Oladunni
  surname: Oluwoye
  fullname: Oluwoye, Oladunni
  organization: Department of Community and Behavioral Health, Elson S. Floyd College of Medicine, Washington State University, Spokane
– sequence: 8
  givenname: Lisa
  surname: Dixon
  fullname: Dixon, Lisa
  organization: Department of Psychiatry, Columbia University Medical Center, New York
– sequence: 9
  givenname: T Scott
  orcidid: 0000-0002-3123-0672
  surname: Stroup
  fullname: Stroup, T Scott
  organization: Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York
– sequence: 10
  givenname: Heidi
  orcidid: 0000-0001-7621-2972
  surname: Guyer
  fullname: Guyer, Heidi
  organization: RTI International, Research Triangle Park, NC
– sequence: 11
  givenname: Natalie
  orcidid: 0000-0002-9067-2075
  surname: Bareis
  fullname: Bareis, Natalie
  organization: New York State Psychiatric Institute, New York
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40887946$$D View this record in MEDLINE/PubMed
BookMark eNpNkEtLxDAcxIOsuA_9AF4kRy9dm0eb5ijrE0TFVa8lSf-xWbpNTVph_fSuuoJzmYH5MYeZolHrW0DomKRzQkR-prrOzdWqm9OU8lSm-R6akIxliaC0GP3LYzSNcZVuxQQ9QGOeFoWQPJ8gew_urdY-1N5XeOmNUw1-HZoWgtKucf0Gq7bCT-qnuHCxU8H1DiJ2LV6a2n36rg7QOoWXHZg-DOtvyocKAn4M8KEaaA0con2rmghHO5-hl6vL58VNcvdwfbs4v0sMZaRPSG4EhSo10krLmeVaa16QquKEyVwyRjKaKmMqK7jQmhkobGaItNpoybmlM3T6u9sF_z5A7Mu1iwaaRrXgh1gyynMmCiayLXqyQwe9hqrsglursCn_vqFfLLhriw
CitedBy_id crossref_primary_10_1176_appi_ajp_20250647
crossref_primary_10_1176_appi_ajp_20250758
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1176/appi.ajp.20240906
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1535-7228
ExternalDocumentID 40887946
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: NIMH NIH HHS
  grantid: L30 MH131131
– fundername: NIMH NIH HHS
  grantid: K23 MH129628
GroupedDBID ---
--Z
-DZ
-~X
.55
1HT
1QT
23M
4.4
5GY
5RE
6J9
7K8
85S
AAIKC
AAJMC
AAMNW
AAWTL
AAWTO
ABIVO
ABPPZ
ABZEH
ACBMB
ACGFO
ACGOD
ACHQT
ACNCT
ADBBV
ADMHG
AENEX
AFAZI
AGHSJ
AHMBA
ALMA_UNASSIGNED_HOLDINGS
ASUFR
BAJDF
BAWUL
CGR
CS3
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EX3
F5P
F8P
FJW
G0H
HF~
HZ~
L7B
MVM
N9A
NHB
NPM
OK1
P2P
PQQKQ
Q.-
RXW
RYA
S10
SJN
TAE
TEORI
TR2
TWZ
UHB
UKR
ULE
UPT
VVN
WH7
WOQ
WOW
X6Y
X7M
XJT
XSW
XZL
YFH
YOC
YRY
YSK
YWH
YZZ
ZCA
ZHY
ZRR
ZY1
7X8
ABUFD
ID FETCH-LOGICAL-c231t-16c72ed0c9f9f43f4bbb481dd413969331520accdf747bb3ce8f5c19fbcb944f2
IEDL.DBID 7X8
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001575356400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1535-7228
IngestDate Sat Nov 01 13:59:42 EDT 2025
Sat Sep 06 11:17:13 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Sociopolitical Issues
Disparities
Schizophrenia Spectrum and Other Psychotic Disorders
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c231t-16c72ed0c9f9f43f4bbb481dd413969331520accdf747bb3ce8f5c19fbcb944f2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-3958-5662
0000-0002-2717-3206
0000-0002-9067-2075
0000-0001-7621-2972
0000-0001-5103-7186
0000-0003-1305-7471
0000-0001-5873-4582
0000-0002-3123-0672
PMID 40887946
PQID 3246378375
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3246378375
pubmed_primary_40887946
PublicationCentury 2000
PublicationDate 2025-Sep-01
20250901
PublicationDateYYYYMMDD 2025-09-01
PublicationDate_xml – month: 09
  year: 2025
  text: 2025-Sep-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The American journal of psychiatry
PublicationTitleAlternate Am J Psychiatry
PublicationYear 2025
SSID ssj0000372
Score 2.4994493
Snippet The study aim was to identify ethnoracial disparities in the prevalence of schizophrenia spectrum disorders (SSDs) and positive psychotic symptoms in the...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 850
SubjectTerms Adult
Black or African American - psychology
Black or African American - statistics & numerical data
Female
Health Status Disparities
Humans
Male
Middle Aged
Neighborhood Characteristics - statistics & numerical data
Prevalence
Psychotic Disorders - epidemiology
Psychotic Disorders - ethnology
Schizophrenia - diagnosis
Schizophrenia - epidemiology
Schizophrenia - ethnology
Social Vulnerability
United States - epidemiology
White - psychology
White - statistics & numerical data
Young Adult
Title Neighborhood Social Vulnerability and Racial Disparities in Schizophrenia Spectrum Disorder Prevalence
URI https://www.ncbi.nlm.nih.gov/pubmed/40887946
https://www.proquest.com/docview/3246378375
Volume 182
WOSCitedRecordID wos001575356400010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3IvhabZssbZ5E1OHLyvDG3kqTNNCh3Vw3wX_vOWnHfBEEX_pSCiU5l-_knHwfIReWcyWZNl5Hs9DjJpPgUpHyIi54oMDGQlWLTURJEg8Gst8cuFXNWOU8JrpAbUYaz8ivIPELFkE51bkef3ioGoXd1UZCY5m0GEAZtOposGAL95kTbwKnRsnWMG66mkEksD1cXGZDZKyEnCZ98TvCdJmmu_nff9wiGw3GpDe1UWyTpbzcIWu9pou-S2yC56Gw-UhpTOsLuvR19oYE1G5W9otmpaGPmXtxV1SoVIjEq7Qo6dPPKT2K8vXTyeydzlk8KXJCZe4m0x556d4_3z54jd6CpwHlTb1A6CjMja-llZYzy5VSHPCsgUQnhWQMcr2faW0s1CBKMZ3HtqMDaZVWknMb7pOVclTmh4RazQAJ6hiKO84NlFgi9llsnYZhoGPVJufzFUzBnrFJkZX5aFalizVsk4N6G9JxTbyRcgyJkoujP3x9TNZDlOp142AnpGXBm_NTsqo_p0U1OXOGAs-k3_sGZeTJZA
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neighborhood+Social+Vulnerability+and+Racial+Disparities+in+Schizophrenia+Spectrum+Disorder+Prevalence&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Anglin%2C+Deidre+M&rft.au=Olfson%2C+Mark&rft.au=van+der+Ven%2C+Els&rft.au=Oh%2C+Hans&rft.date=2025-09-01&rft.eissn=1535-7228&rft.volume=182&rft.issue=9&rft.spage=850&rft_id=info:doi/10.1176%2Fappi.ajp.20240906&rft_id=info%3Apmid%2F40887946&rft_id=info%3Apmid%2F40887946&rft.externalDocID=40887946
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1535-7228&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1535-7228&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1535-7228&client=summon